关注
Anju Murayama
Anju Murayama
其他姓名村山安寿
Tohoku University School of Medicine
在 dc.tohoku.ac.jp 的电子邮件经过验证
标题
引用次数
引用次数
年份
Pharmaceutical company payments to dermatology clinical practice guideline authors in Japan
A Murayama, A Ozaki, H Saito, T Sawano, Y Shimada, K Yamamoto, ...
PLoS One 15 (10), e0239610, 2020
412020
Evaluation of conflicts of interest among participants of the Japanese nephrology clinical practice guideline
A Murayama, K Yamada, M Yoshida, Y Kaneda, H Saito, T Sawano, ...
Clinical Journal of the American Society of Nephrology 17 (6), 819-826, 2022
352022
Pharmaceutical payments to Japanese certified hematologists: a retrospective analysis of personal payments from pharmaceutical companies between 2016 and 2019
E Kusumi, A Murayama, S Kamamoto, M Kawashima, M Yoshida, H Saito, ...
Blood Cancer Journal 12 (4), 54, 2022
322022
Financial conflicts of interest between pharmaceutical companies and the authors of urology clinical practice guidelines in Japan
K Yamamoto, A Murayama, A Ozaki, H Saito, T Sawano, T Tanimoto
International Urogynecology Journal 32, 443-451, 2021
322021
Financial and Intellectual Conflicts of Interest Among Japanese Clinical Practice Guidelines Authors for Allergic Rhinitis
A Murayama, F Kida, A Ozaki, H Saito, T Sawano, T Tanimoto
Otolaryngology--head and neck surgery: official journal of American Academy …, 2021
292021
Trend in industry payments to infectious disease physicians in the United States: a seven-year analysis of nonresearch payments from the Open Payments Database between 2014 and …
A Murayama, K Nakano, S Kamamoto, M Sato, H Saito, T Tanimoto, ...
Clinical Microbiology and Infection 28 (12), 1655. e1-1655. e4, 2022
272022
Evaluation of financial conflicts of interest and drug statements in the coronavirus disease 2019 clinical practice guideline in Japan
T Hashimoto, A Murayama, H Mamada, H Saito, T Tanimoto, A Ozaki
Clinical Microbiology and Infection 28 (3), 460-462, 2022
272022
Financial payments made by pharmaceutical companies to the authors of Japanese hematology clinical practice guidelines between 2016 and 2017
K Harada, A Ozaki, H Saito, T Sawano, K Yamamoto, A Murayama, ...
Health Policy 125 (3), 320-326, 2021
262021
Evaluation of financial conflicts of interest and quality of evidence in Japanese gastroenterology clinical practice guidelines
A Murayama, S Kamamoto, N Murata, R Yamasaki, K Yamada, ...
Journal of Gastroenterology and Hepatology 38 (4), 565-573, 2023
252023
Trend in industry payments to rheumatologists in the United States during the COVID-19 pandemic between 2013 and 2021
A Murayama, S Kamamoto, K Higuchi, H Shigeta, A Ozaki
The Journal of Rheumatology 50 (4), 575-577, 2023
252023
Industry payments to allergists and clinical immunologists in the United States during the coronavirus disease 2019 pandemic
A Murayama, S Kamamoto, H Saito, T Tanimoto, A Ozaki
Annals of Allergy, Asthma & Immunology 129 (5), 635-636, 2022
252022
Pharmaceutical company payments to authors of the Japanese clinical practice guidelines for hepatitis C treatment
F Kida, A Murayama, H Saito, A Ozaki, Y Shimada, T Tanimoto
Liver International 41 (3), 464-469, 2021
252021
Cross-country student perceptions about online medical education during the COVID-19 pandemic
T Suzuki, A Murayama, Y Kotera, D Bhandari, Y Senoo, Y Tani, K Harada, ...
International Journal of Environmental Research and Public Health 19 (5), 2840, 2022
242022
A 9-year investigation of healthcare industry payments to pulmonologists in the United States
A Murayama, H Kugo, Y Saito, H Saito, T Tanimoto, A Ozaki
Annals of the American Thoracic Society 20 (9), 1283-1292, 2023
232023
Evaluation of Financial and Nonfinancial Conflicts of Interest and Quality of Evidence Underlying Psoriatic Arthritis Clinical Practice Guidelines: Analysis of Personal …
H Mamada, A Murayama, S Kamamoto, Y Kaneda, M Yoshida, S Sugiura, ...
Arthritis Care & Research 75 (6), 1278-1286, 2023
222023
Nature and trends in personal payments made to the respiratory physicians by pharmaceutical companies in Japan between 2016 and 2019
A Murayama, M Hoshi, H Saito, S Kamamoto, M Tanaka, M Kawashima, ...
Respiration 101 (12), 1088-1098, 2022
212022
Undisclosed financial conflicts of interest with pharmaceutical companies among the authors of the Esophageal Cancer Practice Guidelines 2017 by the Japan Esophageal Society
A Murayama, S Kamamoto, H Shigeta, H Saito, E Yamashita, T Tanimoto, ...
Diseases of the Esophagus, 2022
212022
Pharmaceutical payments to Japanese board-certified infectious disease specialists: a four-year retrospective analysis of payments from 92 pharmaceutical companies between 2016 …
A Murayama, S Kamamoto, H Saito, K Yamada, D Bhandari, I Shoji, ...
International Journal of Environmental Research and Public Health 19 (12), 7417, 2022
212022
Japan’s Drug Regulation During the COVID‐19 Pandemic: Lessons From a Case Study of Favipiravir
M Ueda, T Tanimoto, A Murayama, A Ozaki, M Kami
Clinical Pharmacology and Therapeutics 111 (3), 545, 2022
212022
Research and nonresearch industry payments to nephrologists in the United States between 2014 and 2021
A Murayama, S Kamamoto, H Kugo, H Saito, A Ozaki
Journal of the American Society of Nephrology 34 (10), 1709-1720, 2023
192023
系统目前无法执行此操作,请稍后再试。
文章 1–20